The Society For Assisted Reproductive Technologies
Home
About Us
What Is SART?
Mission Statement
The SART Executive Council
NCOART
Contact Us
IVF Success Rates
Find a Clinic
National Data Summary
For Patients
Patients Resources
Patient Benefits
What is an Infertility Specialist?
Assisted Reproductive Technologies
Success Rates
Patient Evaluation
ART: Step-by-Step Guide
Who Is To Report ART Cycles?
Fact Sheets and Info Booklets
Frequently Asked Questions (FAQs)
Topics Index
Research
Research Overview
Guidelines for Requesting a SART Data Set
Members
Join SART
Member Login
SART Links
Links
Career Opportunities
SART Resources
Publications
News and Research
Fertility and Sterility
Journal of Assisted Reproduction and Genetics
Menopausal Medicine
Sexuality, Reproduction and Menopause
Ethics Committee Documents
Practice Committee Documents
For Patients
Patients Resources
Patient Benefits
A Patient's Guide to Assisted Reproductive Technology
Introductory Letter
General Information
What is an Infertility Specialist?
Assisted Reproductive Technologies
ART Candidates
Success Rates
Patient Evaluation
ART: Step-by-Step Guide
Preparing for IVF: Emotional Considerations
ART Medications
Minimal Stimulation IVF-ET
Collection of Semen
Oocyte Retrieval and Embryo Transfer
Micromanipulation
Cryopreservation of Embryos
Cryopreserved Embryo Transfer
Donor Oocyte
Questions and Answers
Cycle Cancellation
Financial Information
Stimulation
Resources
Who Is To Report ART Cycles?
Fact Sheets and Info Booklets
FAQs on IVF
FAQs on Infertility
Topics Index
Print this Page
Bookmark this Page
Email this Page
Print this Page
Bookmark this Page
Email this Page
For Patients:
A Patient's Guide to Assisted Reproductive Technology
›
General Information
›
Oocyte Retrieval and Embryo Transfer
Day of hCG Administration
Lupron® is discontinued when hCG is given.
hCG is given when mature follicles are present on ultrasound.
5,000 or 10,000 units of hCG are given intramuscularly at the time indicated by the nurse, depending on the time of retrieval. 250 mcg of Ovidrel (recombinant hCG) can also be used subcutaneously.
Alternatively, Lupron®, 1 mg or 20 units may be used to trigger follicle maturation. This can only be used in cycles utilizing a GnRH antagonist.
Following Retrieval
Following oocyte retrieval, you will be discharged home within approximately 1-2 hours.
You may not be fully alert for several hours after discharge. Do not drive after being discharged on the day of retrieval.
Limit your activity for 24 hours after the procedure.
Medications - Some programs prescribe antibiotics or steroids before embryo transfer. Follow the instructions given to you by your providers.
Call the office if you experience any of the following problems:
Difficulty breathing
Excessive bleeding
Severe pain
Fever
Any other disturbing problems
Progesterone Supplementation
Progesterone may be administered intramuscularly, orally, and/or vaginally, depending on your physician's instructions. Supplementation is maintained until a negative beta hCG or until discontinuation is recommended with a viable pregnancy.
The dosage of progesterone may vary in some instances based on the patient's history.
Pregnancy Follow-up
An initial pregnancy test is obtained 9-13 days after the embryo transfer and is repeated as necessary.
If pregnant, an ultrasound scan is recommended approximately four weeks after embryo transfer to assess the pregnancy.
The patient will return to her obstetrician after ultrasound confirmation of a viable pregnancy to continue prenatal care.